{"protocolSection":{"identificationModule":{"nctId":"NCT03350919","orgStudyIdInfo":{"id":"69879"},"organization":{"fullName":"University of Rochester","class":"OTHER"},"briefTitle":"Visual Restoration for Hemianopia","officialTitle":"Visual Restoration for Hemianopia"},"statusModule":{"statusVerifiedDate":"2020-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-03-15","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-12-03","type":"ACTUAL"},"completionDateStruct":{"date":"2019-12-03","type":"ACTUAL"},"studyFirstSubmitDate":"2017-11-18","studyFirstSubmitQcDate":"2017-11-18","studyFirstPostDateStruct":{"date":"2017-11-22","type":"ACTUAL"},"resultsFirstSubmitDate":"2020-12-01","resultsFirstSubmitQcDate":"2020-12-23","resultsFirstPostDateStruct":{"date":"2020-12-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-12-23","lastUpdatePostDateStruct":{"date":"2020-12-24","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Steven Feldon","investigatorTitle":"Professor and Chair of Ophthalmology","investigatorAffiliation":"University of Rochester"},"leadSponsor":{"name":"University of Rochester","class":"OTHER"},"collaborators":[{"name":"Envision Solutions, LLC","class":"UNKNOWN"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true},"descriptionModule":{"briefSummary":"The purpose of this research is to assess the efficacy of a visual training task on reducing the size of a visual field deficit caused by brain damage in adults, and its ability to improve visual functions in this patient population."},"conditionsModule":{"conditions":["Stroke Induced Vision Loss","Hemianopia","Quadrantanopia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":48,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Training in the blind field","type":"EXPERIMENTAL","description":"Training in the blind field using software","interventionNames":["Device: Training in the blind field"]},{"label":"Training in the intact field","type":"EXPERIMENTAL","description":"Training in the intact field using software","interventionNames":["Device: Training in the intact field"]}],"interventions":[{"type":"DEVICE","name":"Training in the blind field","description":"A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.","armGroupLabels":["Training in the blind field"]},{"type":"DEVICE","name":"Training in the intact field","description":"A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.","armGroupLabels":["Training in the intact field"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"24-2 Humphrey PMD Change From Baseline to 6-month Post-training Timepoint","description":"Change in the perimetric mean deviation (PMD) generated by standard Humphrey automated perimetry using a 24-2 testing pattern between baseline and post-training after a 6-month training interval.","timeFrame":"6 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ages 21-75 years old\n* Ability and willingness to sign informed consent\n* Willingness to participate in both the training and evaluation sessions\n* MRI or CT scan demonstrating lesion in the occipital lobe of the brain and/or affecting white matter tracts that provide visual input to the occipital lobe of the brain\n* Brain injury due to ischemic or hemorrhagic causes that occurs after age 18 and at least 90 days prior to screening visit\n* At least two reliable HVF's demonstrating good fixation and a stable homonymous incomplete (e.g., quadrantanopia or relative defect) or complete hemianopia\n* Reliable HVFs with repeat HVFs if randomization takes place more than 4 weeks after screening visit\n* A homonymous, contiguous visual deficit measured by the 24-2 HVF to be a minimum of two testing locations high and two testing locations wide, where impaired locations are any that measure a threshold of less than 15 dB.\n* Demonstration of good fixation on visual training task - able to fixate the small targets presented as fixation letters reliably for 1000ms with jitter over less than 1 degree of visual angle in any direction away from target edge\n\nExclusion Criteria:\n\n* Physical, neurological or mental disability that would interfere with study intervention\n* Concurrent participation in \"vision therapy\" other than standard occupational or physical therapy\n* Unreliable visual fields on prior testing, indicated by greater than 20% fixation losses, false positives, or false negatives.\n* Inability to discontinue medications judged to affect training and/or assessment (e.g., Ritalin, amphetamines, dopamines, or chemotherapeutic agents)\n* Physical condition likely to preclude completion of the clinical trial (e.g. end-stage or uncontrolled cancer, uncontrolled epilepsy, or end-stage heart disease)\n* Ocular or neurological condition that would interfere with training or assessment (e.g. damage to the optic nerves or lateral geniculate nucleus, any degenerative ocular condition)\n* Best corrected vision worse than 20/40\n* Impaired foveal Humphrey sensitivity as indicated by the HVF tests.\n* Presence of vision loss resulting from ocular disease or disorder\n* Presence of bilateral visual acuity loss from any source\n* Inability to demonstrate fixation stability on eye movement monitored testing\n* Inability to follow training instructions","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Bascom Palmer Eye Institute, University of Miami Health Services","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Flaum Eye Institute, University of Rochester Medical Center","city":"Rochester","state":"New York","zip":"14642","country":"United States","geoPoint":{"lat":43.15478,"lon":-77.61556}},{"facility":"Scheie Eye Institute","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}}]},"ipdSharingStatementModule":{"ipdSharing":"YES"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"No subjects were excluded from the study between recruitment and randomization to assigned groups.","groups":[{"id":"FG000","title":"Training in the Blind Field","description":"Training in the blind field using software\n\nTraining in the blind field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks."},{"id":"FG001","title":"Training in the Intact Field","description":"Training in the intact field using software\n\nTraining in the intact field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"25"},{"groupId":"FG001","numSubjects":"23"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"23"},{"groupId":"FG001","numSubjects":"23"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Training in the Blind Field","description":"Training in the blind field using software\n\nTraining in the blind field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks."},{"id":"BG001","title":"Training in the Intact Field","description":"Training in the intact field using software\n\nTraining in the intact field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"48"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"57.4","spread":"10.8"},{"groupId":"BG001","value":"61.5","spread":"9.4"},{"groupId":"BG002","value":"59.3","spread":"10.5"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"11"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"37"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"48"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"48"}]}]}]},{"title":"Preliminary deficit size","description":"The total area of the subject's deficit, as measured by Humphrey perimetry using a 24-2 testing pattern. This value was calculated by combining testing results from both eyes and interpolating between the tested points to a resolution of 0.1 deg of visual angle. Regions of the visual field with a pattern deviation value (as measured by the Humphrey perimeter) of less than -5 dB were then recorded as part of the deficit. The total area of these combined regions is reported here in square degrees of visual angle.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"square degrees of visual angle","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"819.7","spread":"190.6"},{"groupId":"BG001","value":"755.2","spread":"167.6"},{"groupId":"BG002","value":"788.8","spread":"181.0"}]}]}]},{"title":"Patients with right sided deficits","description":"Total number of patients with a visual deficit localized to the right hand side of the visual field. The number of patients with a left-side localized deficit is the difference between the total number of subjects and the right-side deficit count.","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"20"}]}]}]},{"title":"Time since lesion","description":"The length of time, in months, between the reported date of the stroke that induced visual loss in a patient and their enrollment in the study.","paramType":"MEDIAN","dispersionType":"INTER_QUARTILE_RANGE","unitOfMeasure":"months","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15.0","lowerLimit":"5.7","upperLimit":"47.3"},{"groupId":"BG001","value":"15.5","lowerLimit":"6.2","upperLimit":"57.6"},{"groupId":"BG002","value":"15.28","lowerLimit":"6.1","upperLimit":"47.3"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"24-2 Humphrey PMD Change From Baseline to 6-month Post-training Timepoint","description":"Change in the perimetric mean deviation (PMD) generated by standard Humphrey automated perimetry using a 24-2 testing pattern between baseline and post-training after a 6-month training interval.","populationDescription":"All subjects that completed the assigned training were included in analysis. Each eye was analyzed independently for the primary outcome measure.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"decibels","timeFrame":"6 months","typeUnitsAnalyzed":"Eyes","denomUnitsSelected":"Eyes","groups":[{"id":"OG000","title":"Training in the Blind Field (Left Eye)","description":"Training in the blind field using software\n\nTraining in the blind field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.\n\nFinal outcomes will be reported independently for Left and Right eyes."},{"id":"OG001","title":"Training in the Intact Field (Left Eye)","description":"Training in the intact field using software\n\nTraining in the intact field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.\n\nFinal outcomes will be reported independently for Left and Right eyes."},{"id":"OG002","title":"Training in the Blind Field (Right Eye)","description":"Training in the blind field using software\n\nTraining in the blind field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.\n\nFinal outcomes will be reported independently for Left and Right eyes."},{"id":"OG003","title":"Training in the Intact Field (Right Eye)","description":"Training in the intact field using software\n\nTraining in the intact field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.\n\nFinal outcomes will be reported independently for Left and Right eyes."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"23"}]},{"units":"Eyes","counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"23"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","lowerLimit":"0.22","upperLimit":"1.47"},{"groupId":"OG001","value":"0.10","lowerLimit":"-0.52","upperLimit":"0.72"},{"groupId":"OG002","value":"0.58","lowerLimit":"0.07","upperLimit":"1.08"},{"groupId":"OG003","value":"0.12","lowerLimit":"-0.38","upperLimit":"0.62"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Adverse event data were collected between initial enrollment and the conclusion of final assessment. For a given subject this period covered approximately 6 months.","description":"Subjects were in open communication with study staff throughout their training period and invited to report any issues if they arose. At the conclusion of training subjects were interviewed and asked to report any adverse events they may have experienced.","eventGroups":[{"id":"EG000","title":"Training in the Blind Field","description":"Training in the blind field using software\n\nTraining in the blind field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the blind field. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.","deathsNumAffected":0,"deathsNumAtRisk":25,"seriousNumAffected":0,"seriousNumAtRisk":25,"otherNumAffected":0,"otherNumAtRisk":25},{"id":"EG001","title":"Training in the Intact Field","description":"Training in the intact field using software\n\nTraining in the intact field: A computer software and chin-rest necessary to perform visual training will be loaned to each patient to use at home. They will perform one to two daily training sessions in their home, consisting of 200-300 trials each. The visual task performed repetitively will involve discriminating the direction of motion of a small cloud of dots located at a pre-determined location in the intact field of vision. The computer program will automatically create a record of patient performance during each home training session. They will train daily (about 40-60 minutes total), 5 to 7 days per week, for at least 24 weeks.","deathsNumAffected":0,"deathsNumAtRisk":23,"seriousNumAffected":0,"seriousNumAtRisk":23,"otherNumAffected":0,"otherNumAtRisk":23}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Steven E. Feldon, MD","organization":"University of Rochester","email":"Steven_Feldon@urmc.rochester.edu","phone":"585-273-1050"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2018-05-09","uploadDate":"2020-12-01T12:04","filename":"Prot_SAP_000.pdf","size":154703}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000006423","term":"Hemianopsia"}],"ancestors":[{"id":"D000014786","term":"Vision Disorders"},{"id":"D000012678","term":"Sensation Disorders"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000001766","term":"Blindness"},{"id":"D000005128","term":"Eye Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9199","name":"Hemianopsia","asFound":"Hemianopia","relevance":"HIGH"},{"id":"M17220","name":"Vision Disorders","relevance":"LOW"},{"id":"M15180","name":"Sensation Disorders","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"},{"id":"M4737","name":"Blindness","relevance":"LOW"},{"id":"M7961","name":"Eye Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC11","name":"Eye Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":true}